July 2024 - QualityStocks

WednesdayJul 31, 2024 2:02 pm

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Announces Date for Release of Q2 2024 Financial Results

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, will release its financial results for the second quarter of 2024 on Aug. 8, 2024, before the market opens. The financial report will cover the three and six month periods ended June 30, 2024. In addition, the company has scheduled a conference call on that same day. The call will begin at 8 a.m. ET. During the call, CEO Dr. Alan Baratz and CFO John Markovich will discuss the results and business outlook. Those wishing to access the call can dial 1-800-717-1738 (domestic) or 1-646-307-1865…

WednesdayJul 31, 2024 1:50 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) to Participate as an Anchor Organization at the 2024 Southeastern United States – Canadian Provinces Business Forum

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is participating as an Anchor Organization and panelist at the 2024 Southeastern United States - Canadian Provinces (“SEUS-CP”) Business Forum. The 2024 SEUS-CP is set to take place August 4-6 in Biloxi, Mississippi; Mississippi is home to Mullen’s commercial EV manufacturing. Mullen is a confirmed Anchor Organization at the event alongside other companies. According to the announcement, this year’s business forum focuses on Advanced Manufacturing (Aerospace and Electric Vehicle Technologies and Components) and the Blue Economy (Shipbuilding, UAVs, Smart Ports Energy, Innovative Materials, Innovative Technologies & Data Analytics, Fisheries &…

WednesdayJul 31, 2024 11:15 am

Canada Crypto Week Set For Aug 11-17, 2024: Anchor Event Blockchain Futurist Conference Hosts Multiple Sub-Events Onsite

Toronto, July 22, 2024 – Canada Crypto Week, a week-long series of Web3 and AI events, is set to take place from August 11-17, 2024 in Toronto, Canada. Blockchain Futurist Conference serves as the anchor event for Canada Crypto Week, providing a central hub for the majority of the week’s activities. Many of the 20+ events during Canada Crypto Week will take place onsite at the conference, offering attendees an interactive and immersive experience. Events include book signings, workshops, networking opportunities, the ETHToronto & ETHWomen Hackathon Experience, and more. This integration ensures that participants can fully engage with the majority…

WednesdayJul 31, 2024 10:30 am

FinovateFall To Host The Premier Fintech Community In New York

FinovateFall 2024 invites investors, insurers, directors, and C-level executives from banks, for two days of networking, discussions, and a fintech showcase at the prestigious Marriott Marquis Times Square, New York. Finovate has been serving the fintech fraternity for over 15 years, spotlighting fintech companies from startups to veterans on a robust networking platform where they can discuss and demo innovative business strategies. Discover and explore the latest trends, strategies, and innovative offerings as world leaders, top banks, notable investors, and decision-makers of the fintech community share their knowledge and ideas at the FinovateFall 2024 in New York. Over 120 eminent…

WednesdayJul 31, 2024 9:45 am

Software Effective Solutions Corp. (SFWJ) Takes Critical Steps Toward Achieving Global Production and Processing Vision

MedCana has identified Colombia’s Antioquia Valley as a perfect location to begin its initial rollout of technology and production The company is working with five subsidiaries in the area, each of which has three licenses to produce, process and export cannabis Equally important to MedCana is working closely with the people of the Antioquia Valley and maintaining its commitments to its investors Cannabis legalization is not exclusive to North America. So far, more than 40 countries have legalized cannabis fully or partially for medical and/or adult use (https://ibn.fm/TdZkM). With its focus on the global horizon, Software Effective Solutions (d/b/a MedCana)…

WednesdayJul 31, 2024 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Produces Notable Findings in Latest Weight Loss Study

Lexaria, a global innovator in drug delivery platforms, has released interim results from its WEIGHT-A24-1 animal study The study sought to explore the impact of its patented DehydraTECH technology on glucagon-like peptide-1 (“GLP-1”) drugs for the potential treatment of diabetes and weight loss, representing a major global market The first 28 days of dosing yielded positive results that Lexaria’s management described as “noteworthy” It also marked a significant milestone for the company and the first time it has used liraglutide in any of its GLP-1 studies Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery enhancement, just released interim…

TuesdayJul 30, 2024 2:23 pm

QualityStocksNewsBreaks – PayPal Holdings Inc. (NASDAQ: PYPL) Surpasses Quarterly Earnings Expectations

PayPal Holdings (NASDAQ: PYPL), a leading digital payments platform, recently reported its quarterly earnings, showcasing a performance that exceeded expectations. The company announced earnings of $1.19 per share, surpassing the Zacks Consensus Estimate of $0.96 per share. This marks an improvement from the $1.16 per share reported a year ago, representing an earnings surprise of nearly 24%. PayPal’s ability to consistently outperform consensus EPS estimates over the last four quarters highlights its robust financial health and operational efficiency. For the quarter ending in June 2024, PayPal posted revenues of $7.89 billion, exceeding the Zacks Consensus Estimate by 1.04%. This revenue figure represents…

TuesdayJul 30, 2024 11:48 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Long-Term Study Results Confirm Positive Results of Developing Treatment for AD

InMed Pharmaceuticals (NASDAQ: INM), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, is reporting on positive results from a long-term study of INM-901. The in vivo preclinical Alzheimer's disease (“AD”) involved seven months of dosing and confirms findings from an earlier short-term pilot study. The company reported that results from the study confirm improvements in cognitive function, memory and locomotor activity and show statistical significance in certain behavioral assessments.According to the announcement, InMed is moving forward with additional molecular analyses to better define the mechanisms of action and…

TuesdayJul 30, 2024 11:15 am

Canada’s Mining Legacy Continues: Torr Metals Inc. (TSX.V: TMET) and Quesnel Terrane Hold Promise for New Discoveries

In 2022, Canadian mines produced 510,782 tonnes of copper in concentrate, with over half originating from British Columbia The Quesnel Terrane, which is home to Torr Metals’ expansive Kolos Copper-Gold Project, has the potential to be instrumental in Canada’s next great copper discoveries Torr’s recent rock sampling confirmed copper porphyry mineralization in outcrop adjacent to Highway 5 in the heart of the southern Quesnel Terrane, with assays returning economic values as high as 4,240 ppm Cu and 1.07 g/t Au Canada stands as a global mining titan, amidst British Columbia becoming the largest copper producer, commanding 53% of total Canadian…

TuesdayJul 30, 2024 10:31 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Inks Exclusive License in ‘Transformational’ Step to Treating GBM

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has entered into an exclusive license agreement with Cortice Biosciences Inc. Through the agreement, CNS Pharmaceuticals has acquired a license as well as the intellectual property rights to a potentially blood-brain-barrier, permeable microtubule inhibitor called TPI 287. The inhibitor is being developed for the treatment of glioblastoma multiforme (“GBM”). In return for the license, CNS Pharmaceuticals will pay Cortice an up-front payment of 616,698 shares of its common stock, as well as the possibility…

Site Search

Company Search

Month: July 2024